Lanean...
Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety
Lipid nanoparticle (LNP) formulated messenger RNA-based (LNP-mRNA) vaccines came into the spotlight as the first vaccines against SARS-CoV-2 virus to be applied worldwide. Long-known benefits of mRNA-based technologies consisting of relatively simple and fast engineering of mRNA encoding for antigen...
Gorde:
| Argitaratua izan da: | Biomedicines |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8151051/ https://ncbi.nlm.nih.gov/pubmed/34068715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9050530 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|